Profusa receives Nasdaq MVLS and bid price deficiency notices; 180-day cure period

Profusa, Inc.

Nasdaq notified Profusa on Sep 11, 2025, that MVLS was below $50M threshold from Jul 29 to Sep 10.
Separate bid price notice for failing to maintain $1.00 minimum closing bid over same period.
Company has until March 10, 2026 to regain compliance; stock continues trading under symbol PFSA.
Compliance requires MVLS >= $50M and bid price >= $1.00 for at least 10 consecutive business days.
If not cured, Profusa may face delisting or could apply to transfer to Nasdaq Capital Market.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.